BioSpace News Archive

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that Samarth Kulkarni, Ph.D., Chief Executive Officer of CRISPR Therapeutics, is scheduled to present at the Wells Fargo 2020 Virtual Healthcare Conference on Thursday, September 10, 2020, at 11:20 a.m. ET. A live webcast of the event will be available on the “Eve

Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that management will participate in the Advanced Therapies Congress & Expo being held virtually September 8-11, 2020. Title: Repair of the microcirculation reverses ischemic tissue damage Presenter: Dougl

TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today that Charles Theuer, M.D., Ph.D., President and CEO, will present a corporate overview at the

- H.C. Wainwright: 22 nd Annual Global Investment Conference - September 14 th – 16 th - Sachs Associates: 20 th Annual Biotech in Europe Forum - September 21 st – 24 th - SVB Leerink: CybeRx Series: Vaccine Forum - September 23 rd & – 24 th

Global Blood Therapeutics, Inc. announced that members of the senior management team will participate in virtual fireside chats at the following investor conferences

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, today provides an update on progress for the U.S. manufacturing of Berubicin, the Company’s lead drug candidate, in preparation for upcoming clinical trials. As previously announced, the Company implemented a dual

Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, today announced that the Company is scheduled to present at two upcoming healthcare investor conferences: Baird 2020 Global Healthcare Conference Date: Thursday, September 10, 2020 Presentation Time: 11:25 a.m. ET Morgan Stanley 18th Annual Global He

AbbVie will participate in the Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16, 2020.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Cantor Virtual Global Healthcare Conference on Thursday, September 17 th at 9:20 a.m. ET . The presentation will be webcast live on the Events and Presentations page under the investor relations section of P

BioTalent Canada announced today that “Career Starter,” one of BioTalent Canada’s newest wage subsidy programs—has generated high levels of interest industry-wide and has exceeded all expectations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200903005089/en/ “We’re encouraged by the overwhelming and rapid response to the Career Starter wage subsidy pr